The study explored factors influencing 30-day mortality in cancer patients with pulmonary embolism, analyzing both suspected (SPE) and unsuspected (UPE) cases.
The cohort consisted of 1,033 patients, with key predictors of mortality identified, such as VTE history, cancer type, disease progression, and vital signs.
Mortality rates differed; truly asymptomatic UPE patients had a lower rate (3%) compared to UPE with symptoms (20%) and SPE (21%), indicating disease severity significantly impacts short-term mortality outcomes.